These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 19552519

  • 1. A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.
    Kassa J, Karasova J, Bajgar J, Kuca K, Musilek K, Kopelikova I.
    J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1040-4. PubMed ID: 19552519
    [Abstract] [Full Text] [Related]

  • 2. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J, Karasova J, Musilek K, Kuca K.
    Toxicology; 2008 Jan 20; 243(3):311-6. PubMed ID: 18054821
    [Abstract] [Full Text] [Related]

  • 3. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
    Kassa J, Karasova JZ, Caisberger F, Musilek K, Kuca K, Jung YS.
    J Enzyme Inhib Med Chem; 2010 Aug 20; 25(4):480-4. PubMed ID: 20233085
    [Abstract] [Full Text] [Related]

  • 4. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J, Karasova JZ, Pavlikova R, Musilek K, Kuca K, Bajgar J, Jung YS.
    Toxicol Mech Methods; 2011 Mar 20; 21(3):241-5. PubMed ID: 21142778
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the therapeutic and reactivating efficacy of newly developed oximes (K117, K127) and currently available oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J, Karasova J, Musilek K, Kuca K, Jung YS.
    Drug Chem Toxicol; 2008 Mar 20; 31(3):371-81. PubMed ID: 18622871
    [Abstract] [Full Text] [Related]

  • 6. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice.
    Kassa J, Karasova JZ, Pavlikova R, Misik J, Caisberger F, Bajgar J.
    J Appl Toxicol; 2010 Mar 20; 30(2):120-4. PubMed ID: 19746406
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods.
    Kassa J, Kuca K, Cabal J, Paar M.
    J Toxicol Environ Health A; 2006 Oct 20; 69(20):1875-82. PubMed ID: 16952906
    [Abstract] [Full Text] [Related]

  • 8. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J, Karasova J, Musilek K, Kuca K, Bajgar J.
    Clin Toxicol (Phila); 2009 Jan 20; 47(1):72-6. PubMed ID: 18686075
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J, Kunesova G.
    J Appl Toxicol; 2006 Jan 20; 26(4):309-16. PubMed ID: 16552727
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium compounds (K206, K269) with currently available oximes against tabun in rats and mice.
    Kassa J, Karasova J, Bajgar J, Kuca K, Musilek K.
    J Enzyme Inhib Med Chem; 2008 Dec 20; 23(6):776-80. PubMed ID: 18608751
    [Abstract] [Full Text] [Related]

  • 11. The evaluation of the reactivating and therapeutic efficacy of three novel bispyridinium oximes (K454, K456, K458) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J, Sepsova V, Musilek K, Horova A.
    Toxicol Mech Methods; 2013 Feb 20; 23(2):94-8. PubMed ID: 22901042
    [Abstract] [Full Text] [Related]

  • 12. A comparison of the reactivating and therapeutic efficacy of newly developed oximes (K347, K628) with commonly used oximes (obidoxime, HI-6) against tabun in rats and mice.
    Kassa J, Karasova JZ, Kuca K, Musilek K.
    Drug Chem Toxicol; 2010 Jul 20; 33(3):227-32. PubMed ID: 20429807
    [Abstract] [Full Text] [Related]

  • 13. A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J, Karasova J.
    Toxicology; 2007 Jan 05; 229(1-2):136-44. PubMed ID: 17141392
    [Abstract] [Full Text] [Related]

  • 14. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats and mice.
    Kassa J, Karasova JZ, Caisberger F, Bajgar J.
    Toxicol Mech Methods; 2009 Nov 05; 19(9):547-51. PubMed ID: 19839724
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the reactivating and therapeutic efficacy of two newly developed oximes (k727 and k733) with oxime k203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J, Sepsova V, Tumova M, Horova A, Musilek K.
    Basic Clin Pharmacol Toxicol; 2015 Apr 05; 116(4):367-71. PubMed ID: 25225130
    [Abstract] [Full Text] [Related]

  • 16. A comparison of reactivating and therapeutic efficacy of newly-developed oximes (K156, K203) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J, Karasova JZ, Musilek K, Kuca K.
    Toxicol Mech Methods; 2009 Jun 05; 19(5):346-50. PubMed ID: 19778210
    [Abstract] [Full Text] [Related]

  • 17. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
    Kassa J, Jun D, Kuca K.
    J Enzyme Inhib Med Chem; 2007 Jun 05; 22(3):297-300. PubMed ID: 17674811
    [Abstract] [Full Text] [Related]

  • 18. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats.
    Kassa J, Jun D, Karasova J, Bajgar J, Kuca K.
    Chem Biol Interact; 2008 Sep 25; 175(1-3):425-7. PubMed ID: 18547554
    [Abstract] [Full Text] [Related]

  • 19. The evaluation of the reactivating and therapeutic efficacy of two novel oximes (K361 and K378) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J, Sepsova V, Tumova M, Musilek K, Horova A.
    Toxicol Mech Methods; 2014 Mar 25; 24(3):173-8. PubMed ID: 24295433
    [Abstract] [Full Text] [Related]

  • 20. The benefit of combinations of oximes for the reactivating and therapeutic efficacy of antidotal treatment of sarin poisoning in rats and mice.
    Kassa J, Karasova JZ, Sepsova V, Caisberger F.
    Basic Clin Pharmacol Toxicol; 2011 Jul 25; 109(1):30-4. PubMed ID: 21235715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.